The metabolic syndrome (MetS) is a constellation of metabolic abnormalities including abdominal obesity, dyslipidemia, hypertension, and disturbed glucose and insulin metabolism [1], all of which were well documented high-risk factors for both cardiovascular diseases (CVD) and type 2 diabetes mellitus [2,3,4]. This evidence concerns the gene INS and metabolic syndrome.